Mutations in inhibin and activin genes associated with human disease

作者：Shelling Andrew N^*

来源：Molecular and Cellular Endocrinology, 2012, 359(1-2): 113-120.

DOI：10.1016/j.mce.2011.07.031

• Inhibin
• Activin
• Premature ovarian failure
• Ovarian cancer
• Genetic disease

Inhibins and activins are members of the transforming growth factor (TGF beta) superfamily, that includes the TGF beta s, inhibins and activins, bone morphogenetic proteins (BMPs) and growth and differentiation factors (GDFs). The family members are expressed throughout the human body, and are involved in the regulation of a range of important functions. The precise regulation of the TGF beta pathways is critical, and mutations of individual molecules or even minor alterations of signalling will have a significant affect on function, that may lead to development of disease or predisposition to the development of disease. The inhibins and activins regulate aspects of the male and female reproductive system, therefore, it is not surprising that most of the diseases associated with abnormalities of the inhibin and activin genes are focused on reproductive disorders and reproductive cancers. In this review, I highlight the role of genetic variants in the development of conditions such as premature ovarian failure, pre-eclampsia, and various reproductive cancers. Given the recent advances in human genetic research, such as genome wide association studies and next generation sequencing, it is likely that inhibins and activins will be shown to play more important roles in a range of human genetic diseases in the future.

• 出版日期2012-8-15